Based on our data, and relevant to this issue, we would like to suggest that staining for Rb S249 phosphorylation in tumor biopsies could be added to the pathology workflow to help minimize the NSCLC-NOS classification when dealing with poorly differentiated tumors. The gene discussed is RB1; the disease is neoplasm.